Delivery Order SPE2DB24D3015-SPE2DB25FGAHM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count units) at a ceiling value of $49,619.13. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,540.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,436.38 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count) with a ceiling value of $24,362.76 under a firm fixed-price contract structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued against the...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,260.33 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same location designated as the place of performance—is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $9,966.32. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and running through December 2026. The...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAHMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,794.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) with a completion date of July 30, 2025. This firm fixed-price delivery order, awarded on July 29, 2025, represents a non-set-aside competitive award with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain through its extensive portfolio of competitively awarded contracts with DLA and other government healthcare entities. The company's federal contract history demonstrates significant capability in delivering a broad spectrum of pharmaceutical products, including diabetes medications, specialty treatments, and medical supplies to support military personnel and veteran healthcare programs. This particular delivery order for Jardiance, a diabetes management medication, exemplifies the routine pharmaceutical procurement activities conducted through the SPE2DX master contract vehicle that enables flexible and efficient sourcing of essential medical commodities across multiple therapeutic domains for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 7/29/25 |